A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ACE2

Search Conditions:
Search Keyword : ACE2
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: ACE2
Appearance Frequency: 2898 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
angiotensin-converting enzyme 2
(2870 times)
Medicine
(261 times)
SARS-CoV-2 (851 times)
COVID-19 (710 times)
RAS (342 times)
2002 Angiotensin-converting enzyme 2 is an essential regulator of heart function.
Ang-converting enzyme 2
(8 times)
Physiology
(2 times)
Ang (4 times)
Ang II (2 times)
RAS (2 times)
2009 Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus.
angiotensin-converting enzyme-related carboxypeptidase 2
(4 times)
Water-Electrolyte Imbalance
(2 times)
Ang II (2 times)
AhR (1 time)
Ang (1 time)
2010 Maternal apelin physiology during rat pregnancy: the role of the placenta.
ACE type 2
(3 times)
Physiology
(2 times)
ACE (2 times)
Ang 1-7 (2 times)
Ang II (2 times)
2012 Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.
ACE2 KI mice
(1 time)
Neurology
(1 time)
BLA (1 time)
EPM (1 time)
MasR (1 time)
2016 Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors.
ACE2-Fc
(1 time)
RBDs (1 time)
SARS-CoV-2 (1 time)
2020 Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2.
ACE2-gene network
(1 time)
--- 2020 ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility.
ACE2/rMAS gene expression compared to the HF group
(1 time)
Gastrointestinal Diseases
(1 time)
ACE (1 time)
Ang II (1 time)
AT1r (1 time)
2019 Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model.
AGS-ACE2
(1 time)
Microbiology
(1 time)
AGS (1 time)
CG (1 time)
RBD (1 time)
2021 Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
10  Altimeter Corrected Elevations 2
(1 time)
Environmental Health
(1 time)
GDEM (1 time)
2011 Evaluation of the differences between the SRTM and satellite radar altimetry height measurements and the approach taken for the ACE2 GDEM in areas of large disagreement.
11  analyses, in male subjects the model of rs2106809
(1 time)
Endocrinology
(1 time)
RAS (1 time)
2010 Interactions among related genes of renin-angiotensin system associated with type 2 diabetes.
12  Ang converting enzyme type 2
(1 time)
Medicine
(1 time)
ACh (1 time)
Ang (1 time)
AP (1 time)
2018 Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.
13  Angiotensin Converting Enzyme 2 Activity in Biological Fluid
(1 time)
Molecular Biology
(1 time)
ADAM-17 (1 time)
Ang (1 time)
CVs (1 time)
2017 Measurement of Angiotensin Converting Enzyme 2 Activity in Biological Fluid (ACE2).
14  antiotensin-converting enzyme homologue 2
(1 time)
Medicine
(1 time)
AT1R (1 time)
DMN (1 time)
ERK (1 time)
2020 Fugan Wan alleviates hepatic fibrosis by inhibiting ACE/Ang II/AT-1R signaling pathway and enhancing ACE2/Ang 1-7/Mas signaling pathway in hepatic fibrosis rat models.
15  same cell entry receptor as SARS-CoV,angiotensin-converting enzyme 2
(1 time)
Biology
(1 time)
SARS-CoV-2 (1 time)
2020 Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.
16  SARS-CoV-2-angiotensin-converting enzyme 2
(1 time)
Genetics
(1 time)
DEG (1 time)
2021 Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age.
17  system-RAAS-Angiotensin converting enzyme 2
(1 time)
Biology
(1 time)
ARDS (1 time)
CD147 (1 time)
COVID-19 (1 time)
2020 Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.